跳至主要内容
临床试验/NCT04807712
NCT04807712招募中不适用

National Surveillance of Pediatric Pertussis in Ambulatory Settings

Association Clinique Thérapeutique Infantile du val de Marne1 个研究点 分布在 1 个国家目标入组 898 人开始时间: 2001年5月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
898
试验地点
1
主要终点
Duration of pertussis vaccines protection

研究概览

简要总结

Since 2002, Whooping cough surveillance in pediatric private practice has been set up in France. The results of the first years, 2002-2006, have confirmed the effectiveness of the Pertussis whole-cell (Pw) vaccine and in particular the duration of protection of 9/10 years. After evaluating cases in children vaccinated with Pw vaccines, the study aims today to analyze cases in children vaccinated with Pertussis acellular (Pa) vaccines used since 2002/2003 and to assess, on an outpatient basis, the impact of new vaccine recommendations in France (in 2013, introduction of a 2 + 1 schedule - 8 weeks, 4 months and a 11-month recall - and a 6-year recall, and in 2014, update in the recommendations of exams to be prescribed based on the child's age and vaccination status).

详细描述

The whooping cough surveillance objectives are :

  • to follow the duration of protection of the Ca vaccines in the context of modifications of the vaccine recommendations
  • to describe the clinical characteristics of a population vaccinated with several boosters
  • to adapt complementary examinations for diagnostic purposes (culture, PCR, serology) according to the evolution of scientific knowledge
  • to monitor B. parapertussis infections
  • to train laboratories with nasopharyngeal aspiration
  • to monitor the evolution of the bacterial species All children aged 0-18 years, in whom the diagnosis of pertussis is mentioned and for which a biological check-up is requested, are included, except asymptomatic children with confirmed family case.

In case of suspected pertussis, real-time PCR and / or culture and / or (rarely) serology is / are still prescribed to the patient and / or his entourage.

Selected Pediatricians from the ACTIV group and the AFPA working in an outpatient clinic, located in different places in France, are participating in this network since 2001. The clinical evolution and the results of the examinations are transcribed on a case report form. The data are collected, firstly, during the visit where the diagnosis of whooping cough is suspected and a biological assessment requested (patient's medical history, clinical data, vaccination status and dates, as well as the search for a contaminated/contaminator) and secondly during the follow-up visit (results of the biological check-up and diagnosis, antibiotics potentially prescribed, and supplement data of the entourage, except in case of diagnosis of pertussis not retained).

All evaluations made by the pediatricians are regularly reviewed during meetings, and final diagnoses used are:

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Day 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • All children under 18 years old with a pertussis diagnosis is suspected and a biological exam is requested

排除标准

  • children without symptoms with a household confirmed case
  • cases for which the pertussis diagnosis was not suspected by the pediatrician

结局指标

主要结局

Duration of pertussis vaccines protection

时间窗: at inclusion

Evaluate the duration of protection of the Ca vaccines

次要结局

  • Clinical characteristics of pertussis(at inclusion)

研究者

发起方
Association Clinique Thérapeutique Infantile du val de Marne
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验